SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-139446
Filing Date
2017-04-26
Accepted
2017-04-26 16:06:00
Documents
9
Period of Report
2017-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d372234d8k.htm 8-K 22817
2 EX-1.1 d372234dex11.htm EX-1.1 160519
3 EX-5.1 d372234dex51.htm EX-5.1 9338
4 EX-99.1 d372234dex991.htm EX-99.1 11137
5 EX-99.2 d372234dex992.htm EX-99.2 11557
6 GRAPHIC g372234ex991p1.jpg GRAPHIC 11251
7 GRAPHIC g372234ex992p1.jpg GRAPHIC 11342
8 GRAPHIC g372234g05j51.gif GRAPHIC 8724
9 GRAPHIC g372234g78i12.gif GRAPHIC 2367
  Complete submission text file 0001193125-17-139446.txt   263483
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 17784371
SIC: 2834 Pharmaceutical Preparations